A study sought to determine the impact of infection, gastrointestinal, bone/muscle, and metabolic/endocrine complications in patients receiving steroids for GVHD on HCRU and costs.
A cross-sectional study sought to determine if multiple breath washout could diagnose pulmonary chronic GVHD in children who cannot adequately achieve maneuvers on spirometry.
Analysis of patient-reported questionnaire results showed predictors of recovery for patients undergoing allo-HSCT.
Three case reports describe the use of vedolizumab in pediatric patients with gastrointestinal acute GVHD, with 2 cases achieving resolution.
Researchers identified multiple characteristics associated with fatigue in patients with chronic GVHD.
An analysis determined the potential for posttransplant cyclophosphamide prophylaxis for GVHD in patients who underwent alloHCT.
Researchers sought to determine if a single dose of posttransplant cyclophosphamide is as effective as a 2-dose regimen in patients undergoing hematopoietic cell transplantation with matched-unrelated donors.
Researchers report on results of a phase 2 clinical trial on a novel agent for the treatment of chronic graft-versus-host-disease in patients who have undergone hematopoietic cell transplantation.
A graft-vs-MDS effect of graft-vs-host disease has been observed for some patients with acute leukemia post-HSCT, but has been less well studied in those with MDS.
For patients receiving HLA-matched sibling donor transplantation, antithymocyte globulin can reduce the incidence of acute graft-vs-host-disease.
